Display options
Share it on

Front Mol Neurosci. 2014 Apr 23;7:30. doi: 10.3389/fnmol.2014.00030. eCollection 2014.

Fatty acids increase neuronal hypertrophy of Pten knockdown neurons.

Frontiers in molecular neuroscience

Catherine J Fricano, Tyrone Despenza, Paul W Frazel, Meijie Li, A James O'Malley, Gary L Westbrook, Bryan W Luikart

Affiliations

  1. Department of Physiology and Neurobiology, Geisel School of Medicine at Dartmouth Lebanon, NH, USA.
  2. The Dartmouth Institute for Health Policy and Clinical Practice, Geisel School of Medicine at Dartmouth Lebanon, NH, USA.
  3. The Vollum Institute, Oregon Health and Science University Portland, OR, USA.

PMID: 24795563 PMCID: PMC4006057 DOI: 10.3389/fnmol.2014.00030

Abstract

Phosphatase and tensin homolog (Pten) catalyzes the reverse reaction of PI3K by dephosphorylating PIP3 to PIP2. This negatively regulates downstream Akt/mTOR/S6 signaling resulting in decreased cellular growth and proliferation. Co-injection of a lentivirus knocking Pten down with a control lentivirus allows us to compare the effects of Pten knockdown between individual neurons within the same animal. We find that knockdown of Pten results in neuronal hypertrophy by 21 days post-injection. This neuronal hypertrophy is correlated with increased p-S6 and p-mTOR in individual neurons. We used this system to test whether an environmental factor that has been implicated in cellular hypertrophy could influence the severity of the Pten knockdown-induced hypertrophy. Implantation of mini-osmotic pumps delivering fatty acids results in increased neuronal hypertrophy and p-S6/p-mTOR staining. These hypertrophic effects were reversed in response to rapamycin treatment. However, we did not observe a similar increase in hypertrophy in response to dietary manipulations of fatty acids. Thus, we conclude that by driving growth signaling with fatty acids and knocking down a critical regulator of growth, Pten, we are able to observe an additive morphological phenotype of increased soma size mediated by the mTOR pathway.

Keywords: PI3K; Pten; fatty acids; mTOR; neuronal hypertrophy; pS6; rapamycin

References

  1. PLoS One. 2011;6(5):e19077 - PubMed
  2. J Neurosci. 2011 Mar 16;31(11):4345-54 - PubMed
  3. Science. 2002 Feb 1;295(5556):868-72 - PubMed
  4. Nat Genet. 2001 Dec;29(4):404-11 - PubMed
  5. J Biol Chem. 2011 Jan 7;286(1):391-402 - PubMed
  6. J Neurosci. 2012 Feb 1;32(5):1643-52 - PubMed
  7. Br J Psychiatry. 2009 Jul;195(1):7-14 - PubMed
  8. Diabetologia. 2003 Oct;46(10):1297-312 - PubMed
  9. Cell. 2008 Oct 31;135(3):401-6 - PubMed
  10. Proc Natl Acad Sci U S A. 1998 Jun 23;95(13):7772-7 - PubMed
  11. Cell. 2012 Apr 13;149(2):274-93 - PubMed
  12. Cell. 2008 Sep 19;134(6):933-44 - PubMed
  13. Oncogene. 2013 Jan 10;32(2):160-70 - PubMed
  14. Am J Med Genet. 2001 Aug 8;105(6):521-4 - PubMed
  15. Autism Res. 2010 Jun;3(3):137-41 - PubMed
  16. J Med Genet. 1998 Nov;35(11):886-9 - PubMed
  17. Science. 2011 Oct 28;334(6055):528-31 - PubMed
  18. Prostaglandins Leukot Essent Fatty Acids. 2011 Nov;85(5):293-302 - PubMed
  19. Pediatrics. 2012 May;129(5):e1121-8 - PubMed
  20. Curr Opin Neurobiol. 2009 Apr;19(2):231-4 - PubMed
  21. Diabetes. 1999 Aug;48(8):1586-92 - PubMed
  22. Nat Rev Genet. 2008 May;9(5):341-55 - PubMed
  23. Neuron. 2006 May 4;50(3):377-88 - PubMed
  24. Diabetes. 2011 Feb;60(2):408-15 - PubMed
  25. Trends Neurosci. 2006 Jul;29(7):349-358 - PubMed
  26. Pediatrics. 2011 Aug;128(2):344-55 - PubMed
  27. J Lipid Res. 2011 Jul;52(7):1319-27 - PubMed
  28. J Med Genet. 2005 Apr;42(4):318-21 - PubMed

Publication Types

Grant support